FIELD: chemistry.
SUBSTANCE: claimed invention relates to field of organic chemistry, namely to novel quinolyl-containing compounds of hydroxamic acid of general formula (I), wherein each of V1 and V2 independently represents halogen; one of R and R' represents group Q, containing hydroxamic acid, and the other represents methoxy, wherein group Q, containing hydroxamic acid, is represented by formula ; A represents O; L represents C1-6alkyl; J represents NH, piperidinyl, or J is absent; X is absent; Y represents C1-6alkyl, or Y is absent. The invention also relates to method for obtaining formula (I) compound, pharmaceutical composition, based on formula (I) compound and its application for treatment of diseases, caused by proteinkinase and/or histone deacetylase activity.
EFFECT: novel compounds, which can be applied in cancer treatment, have been obtained.
25 cl, 7 dwg, 7 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
QUINOLINE-LIKE COMPOUND SUBSTITUTED BY PHOSPHORUS-CONTAINING GROUP, METHOD FOR PREPARING IT, THERAPEUTIC COMPOSITION CONTAINING THIS COMPOUND AND USING IT | 2011 |
|
RU2551274C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
ANTICANCER AGENT INVOLVING COMBINATIONS OF KINASE INHIBITORY COMPOUNDS | 2011 |
|
RU2560683C2 |
METHOD OF OBTAINING HYDROXAMIC ACIDS, DERIVATIVES OF 2-ARYL-2.3-DIHYDROQUINAZOLIN-4(1H)-ONES | 2020 |
|
RU2744750C1 |
PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS | 2011 |
|
RU2573834C2 |
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS | 2013 |
|
RU2627706C2 |
HYDROXAMIC ACIDS, DERIVATIVES OF 4-AMINOQUINAZOLINE-7-CARBOXYLIC ACID AS INHIBITORS OF HISTONE DEACETYLASE, AND METHOD FOR SYNTHESIS THEREOF | 2021 |
|
RU2779981C1 |
Authors
Dates
2016-01-27—Published
2011-09-27—Filed